Y-mAbs Therapeutics, Inc. (20) | Uncategorized (6)
Recent Contracts
-
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 1, 2022)
-
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 1, 2021)
-
Master Sponsored Research Agreement effective as of October 7, 2020 by and between the Company and Memorial Sloan Kettering Cancer Center
(Filed With SEC on October 8, 2020)
-
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 12, 2020)
-
Y-mAbs Sublicense Agreement, dated as of June 27, 2018, by and between the Company and MabVax Therapeutics Holdings, Inc
(Filed With SEC on December 19, 2019)
-
Amended and Restated Sponsored Research Agreement effective as of September 13, 2019 by and between the Company and Memorial Sloan Kettering Cancer Center
(Filed With SEC on September 19, 2019)